Hjem › Eggstokkreft › Ohio › Toledo
Kliniske studier for Eggstokkreft i Toledo, OH
12 studier for Eggstokkreft søker deltakere på steder i og rundt Toledo (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruttererFase 2
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health - Perrysburg Hospital, Perrysburg · 8 mi unna
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
RekruttererFase 1
- Site 06, Maumee · 9 mi unna
DESTINY-PANTUMOUR04
RekruttererObservasjonsstudie
- Research Site, Maumee · 9 mi unna
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RekruttererFase 3
- ProMedica Flower Hospital, Sylvania · 9 mi unna
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RekruttererFase 3
- Promedica Flower Hospital, Sylvania · 9 mi unna
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RekruttererObservasjonsstudie
- Toledo Clinic Cancer Center, Toledo
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
RekruttererFase 3
- ProMedica Flower Hospital, Sylvania · 9 mi unna
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RekruttererFase 1
- Normunity Investigational Site, Maumee · 9 mi unna
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Rekrutterer
- ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo
- ProMedica Flower Hospital, Sylvania · 9 mi unna
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekruttererFase 3
- ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo
- ProMedica Flower Hospital, Sylvania · 9 mi unna
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Taylor Cancer Research Center, Maumee · 9 mi unna
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RekruttererFase 2
- Taylor Cancer Research Center, Maumee · 9 mi unna
Eggstokkreft-studier i andre byer
- Houston, TX89 studier
- New York City, NY69 studier
- Boston, MA61 studier
- Los Angeles, CA50 studier
- Nashville, TN49 studier
- Arlington, VA46 studier
- Philadelphia, PA44 studier
- Columbus, OH39 studier
- St. Louis, MO38 studier
- Chicago, IL36 studier
- San Antonio, TX31 studier
- Cleveland, OH30 studier
Andre studier i Toledo
- Ikke-småcellet lungekreft17 studier
- Lungekreft11 studier
- Metastatisk kreft10 studier
- Slag9 studier
- Plateepitelcancer i hode og hals8 studier
- Endometriekreft8 studier
- Melanom8 studier
- Pankreaskreft8 studier
- Prostatakreft7 studier
- Spiserørkreft7 studier
- Iskemisk slag7 studier
- Hjertesvikt7 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.